Exploring Talc-Related Cancer Lawsuits: Avon's Financial Crisis
mesowatch
The Fall of an Icon: Avon Files Chapter 11 Bankruptcy
divider

Avon’s Financial Turmoil: Chapter 11 Bankruptcy Amid Talc-Related Cancer Lawsuits

Avon’s Financial Turmoil: Chapter 11 Bankruptcy Amid Talc-Related Cancer Lawsuits

Katie Duquette

Reading Time: 5 mins

Published On: August 13, 2024

Katie Duquette - editor

Katie Duquette, Esquire, edits our legal and medical content. She works as a clinical research coordinator in neurology at Thomas Jefferson University and received her law degree in 2016 from Villanova University School of Law. She is a licensed attorney in the District of Columbia.

More to Read

divider

August 27, 2024

J&J’s Talc Legal Battles: Medical Monitoring and Settlement

>READ

divider

August 26, 2024

The Asbestos Lawsuit Process: From Diagnosis to Legal Action

>READ

divider

August 24, 2024

Talc Settlement Disputes Keep Doors Open for Future Claims Against J&J

>READ

divider

August 22, 2024

GAG-DP Biomaterial Advances Mesothelioma Research

>READ

divider

August 21, 2024

$59.7M Transfer Triggers Legal Battle Over Asbestos Claims

>READ

divider

August 18, 2024

Pleural and Peritoneal Mesothelioma Found in Female Patient

>READ

divider

News & Data

divider

FILTER:

search
divider
Is J&J Playing Fair? Lawyers Dispute the $1.1 Billion Talc Settlement Increase
Is J&J Playing Fair? Lawyers Dispute the $1.1 Billion Talc Settlement Increase

Matthew Davis
3 mins read - September 14, 2024

On September 4, Johnson & Johnson boldly announced a $1.1 billion increase to its proposed talc settlement, This would increase the settlement to more than $9 billion paid...

Settlements

J&J Raises Talcum Powder Settlement by Another $1.1 Billion
J&J Raises Talcum Powder Settlement by Another $1.1 Billion

Matthew Davis
3 mins read - September 10, 2024

Johnson & Johnson is planning to pay an additional $1.1 billion in its proposed settlement to clear up tens of thousands of lawsuits alleging the company, and its baby powder...

Featured

FDA Clears Insilico Medicine’s AI-Discovered Drug for Mesothelioma
FDA Clears Insilico Medicine’s AI-Discovered Drug for Mesothelioma

Amna Anees
5 mins read - August 28, 2024

In a groundbreaking development, the U.S. Food and Drug Administration (FDA) has granted Investigational New Drug (IND) clearance to Insilico Medicine’s ISM6331, a potential...

Research

J&J’s Talc Legal Battles: Medical Monitoring and Settlement
J&J’s Talc Legal Battles: Medical Monitoring and Settlement

Melissa Bill
5 mins read - August 27, 2024

The consumer products behemoth Johnson & Johnson is now submerged under a barrage of lawsuits accusing the company’s talc-based products of being the root cause of their...

Settlements

The Asbestos Lawsuit Process: From Diagnosis to Legal Action
The Asbestos Lawsuit Process: From Diagnosis to Legal Action

Katie Duquette
6 mins read - August 26, 2024

Asbestos lawsuits are critical for individuals diagnosed with mesothelioma, lung cancer, or other asbestos-related ailments. Such diagnoses can lead to major life adjustments, and...

Awareness

Talc Settlement Disputes Keep Doors Open for Future Claims Against J&J
Talc Settlement Disputes Keep Doors Open for Future Claims Against J&J

Matthew Davis
4 mins read - August 24, 2024

The complex negotiations surrounding Johnson & Johnson’s $6.5 billion attempt to settle thousands of lawsuits regarding its talc products have hit a stumbling block,...

Settlements


August 22, 2024

GAG-DP Biomaterial Advances Mesothelioma Research

>READ

divider

August 21, 2024

$59.7M Transfer Triggers Legal Battle Over Asbestos Claims

>READ

divider

August 18, 2024

Pleural and Peritoneal Mesothelioma Found in Female Patient

>READ

divider

August 17, 2024

Study Finds State-Level Trends and Asbestos-Talc Risks

>READ

divider

August 16, 2024

What The J&J $63.4M Talc Lung Cancer Verdict Means for You

>READ

divider

August 16, 2024

The End of Asbestos: EPA’s Historic Ban and Its Implications

>READ

divider

August 16, 2024

Talc Lung Cancer Lawsuit Costs Johnson & Johnson $63.4 Million

>READ

divider

August 15, 2024

PET/CT Enhancing Diagnosis and Treatment of Pleural Mesothelioma

>READ

divider

August 14, 2024

Secondary Exposure Emerges as a Hidden Threat in the Ongoing Asbestos Crisis

>READ

divider

Browse Categories

divider

Copyright © 2024 by Mesowatch. All Rights Reserved.
The information on this website is proprietary and protected by law. It is not, nor should it be taken as medical or legal advice. None of the content on this site is intended to substitute for professional medical advice, diagnosis, treatment, or legal counsel. Any unauthorized use, copying, or dissemination will be prosecuted to the fullest extent of the law. Please read our disclaimer for more details.DMCA.com Protection Status